Scheduled for Saturday, May 10, 2025, at the historic St. Louis Union Station Hotel, An Evening with the Blues will bring together hockey fans, community members, and supporters for a night of unforgettable entertainment!
Read MoreTrial taking place at Sheikh Khalifa Medical City, a flagship tertiary hospital in the United Arab Emirates
POC data generated from this study could potentially lead to reimbursed early patient access in certain European countries for crofelemer for MVID
Crofelemer, Jaguar's novel plant-based prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and short bowel syndrome with intestinal failure (SBS-IF)
Read MoreFree to participants in the 2025 survey of BHIT software, this comprehensive report offers critical insights into trends, developments, and vendor capabilities shaping the future of behavioral health IT.
Read MoreThe FEMSA Biotechnology Center at Tecnologico de Monterrey (Mexico's number one university in engineering and technology, in LATAM according to the QS World Ranking 2024) has worked for over 25 years on the development of nutraceutical corn, a genetically improved variety that is not only nutritious but can also contribute to the prevention of chronic degenerative diseases.
This project is led by experimental biologist and researcher Silverio García-Lara, PhD.
Read MoreAs a new Marketplace partner, WCH joins an expansive, open ecosystem that allows for integration with third-party applications, services, and systems to make innovative solutions available to more than 160,000 providers on the athenaOne network. The Marketplace allows athenaOne customers the ability to access and efficiently integrate with solutions that augment the functionality of the athenaOne platform, helping providers and administrators eliminate friction for patients while working to improve practice outcomes and financial performance
Read MoreDr. Amir Bajoghli and Skin & Laser Dermatology Center are excited to introduce advanced laser treatments for telangiectasia, offering patients effective solutions to reduce the appearance of small, visible blood vessels.
Read MoreAlso giving an in-session talk titled "Modular Multispecific Biotherapeutics: Rapid Therapeutic Design with the ADAPTIR® Platform," showcasing Aptevo's drug engineering and rational drug design expertise
Read More
The Columbia-based company drove over 1,000% Revenue Growth since 2021, driven by actuarially validated outcomes, New and Expanded Strategic Partnerships, and Industry Recognition
Read More